CD274 and colorectal carcinoma: However, future work is needed to identify CRC patients suitable for immunotherapy and characterize repertoires of T-cells to be targeted, a point illustrated by studies showing the presence of intra-tumoural CD103+CD8+ T cells predicts responses to PDL-1 blockade (46, 47).